Imaging & Diagnostics

Using OCT to evaluate fluid in non-neovascular AMD

How optical coherence tomography, OCT angiography and fluorescein angiography can help direct diagnosis and treatment decisions.

How imaging is advancing management of dry AMD

Emerging modalities and deep learning are helping to expose an old foe in non-neovascular age-related macular degeneration: reticular pseudodrusen.

Imaging biomarkers and precision medicine

Advances in computational power, and machine learning and diagnostic systems are creating new opportunities for understanding disease mechanisms.

Retinal sequelae of novel oncology drugs

Getting to the cause of blurred vision in a man with Erdheim-Chester disease.

Will biosimilars find their place in retina?

With patents expiring, an approval pending and legislation aimed at easing regulations, more biosimilars could be coming. But are retina specialists ready?

Retinal sequelae of novel oncology drugs

Getting to the cause of blurred vision in a man with Erdheim-Chester disease.

AI in retina: Ready for prime time?

Artificial intelligence is ready to be incorporated into retina referral networks. Here’s a look at the state of the science.

FAF, OCT demystify blurred vision cause

How multimodal imaging helped to elucidate an insidious nutritional deficiency.

Signature OCT findings as a diagnostic tool

How imaging helped diagnose neurofibromatosis type 1, retrograde trans-synaptic degeneration, bacillary detachment and photothermal injury.

How UWF imaging can guide anti-VEGF therapy in PDR

We report on our experience using ultra-widefield imaging to evaluate endolaser-less vitrectomy in eyes with vitreous hemorrhage.

Video Vault

Minimally invasive management of lenticular deposits

Akshay Thomas, MD, MS, of Tennessee Retina demonstrates his surgical technique for removing posterior intraocular lens deposits.